2021 BIOPACIFIC CONFERENCE
Theme: Passion for Better Medicine
Virtual Zoom Conference
| 8:30 AM – 8:50 AM | Breakout Room Networking |
| 8:50 AM – 8:55 AM | Welcome Remarks Carrie Wang, MD, President-elect of CABS and 2021 BioPacific Conference Organizing Committee Chair |
| 8:55 AM – 9:00 AM | State of the Society Yan Wang, PhD, President of CABS |
| 9:00 AM – 9:35 AM | Keynote #1: Traffic of Cas9-gRNA Between Cultured Human Cells Mediated by Cell-Cell Contact Randy Schekman, PhD, Professor, Department of Molecular and Cell Biology, UC Berkeley 2013 Nobel Prize for Physiology or Medicine |
| 9:35 AM – 10:00 AM | CABS K. Fong Award in Life Sciences Presenter: Kenneth Fong, PhD, Chairman, Kenson Ventures Awardees: John O. Link, PhD, Former VP, Gilead (Retired 2020) Xianping Lu, PhD, Founder, Chairman and CEO, ChipScreen BioSciences |
| 10:00 AM–10:25 AM | K. Fong Award Speech: Reshaping Biotech Landscape in China Xianping Lu, PhD, Founder, Chairman and CEO, ChipScreen BioSciences |
| 10:25 AM – 10:50 AM | Enoxaparin: A Twice-Yearly Dosed First-in-Class HIV Capsid Inhibitor John O. Link, PhD , Former VP, Gilead (Retired 2020) |
| 10:50 AM – 11:20 AM | Cancer Immunotherapy Trends and Highlights in the Post-Checkpoint Inhibitor Approval Era
Gary Starling, PhD, CSO, Xyphos-Astellas Pharma Inc |
| 11:20 AM – 12:00 PM | Panel Discussion 1: IP Considerations and Investment trends for Life Sciences This session will cover intellectual property considerations for life science transactions and stories of investment in new technologies. Options to structure a new company will be discussed. Moderator: Janet Xiao, PhD, JD, Partner, Head of MoFo’s China Life Sciences, Morrison & Foerster LLP Panelists:Chuck Comey, Partner, Morrison & Foerster LLP Sean Cao, PhD, MBA, Managing Director, the CBC Group Neil Desai, PhD, Founder & CEO, AADI |
| 12:00 PM – 12:30 PM | Breakout room talks Room 1: Effective Use of Science in the FDA Regulatory Process Bethany Hills, PhD, Partner, Morrison & Foerster LLP Keunbong (KB) Do, Associate, Morrison & Foerster LLPRoom 2: Precise and Efficient Non-viral CRISPR Gene Editing Solutions Lumeng Ye, PhD, Sr. Scientist, GenScript USA Inc Room 3: Room 4: Room 5: |
| Afternoon Session | |
| 12:30 PM – 1:05 PM | Keynote #2: Towards Universal Druggability Gregory L. Verdine, PhD, Professor, Chemical Biology, Harvard |
| 1:05 PM – 1:35 PM | How we Use Stem Cells & Genomics for Guiding Precision Medicine Joseph Wu, MD, PhD, Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University. |
| 1:35 PM – 2:05 PM | Designing Better Molecules Faster and with Less Expense: Illustrations of the Transformative Impact of Physics-Based Modeling Combined with Machine Learning Matt Repasky, PhD, SVP, Life Sciences Products, Schrodinger Inc (Boston) |
| 2:05 PM – 2:35 PM | The COVID-19 Pandemic: A Status Report Arthur Reingold,, Professor and Head of the Division of Epidemiology at the School of Public Health, UC Berkeley |
| 2:35 PM – 3:15PM | Panel Discussion 2: Strategic Partnerships & Financing Trends for the Biotech Industry Moderator: Cheni Kwok, PhD, CLP, Managing Partner & Founder Panelists: Edward, Harrington, MBA, CFO of Genentech Guo-Liang Yu, PhD, CEO, Apollomics Dewan Zeng, PhD, Executive Director of BeiGene Chen Yu, MD, MBA, Founder and Managing Partner, TCG |
| 3:15 PM – 3:45 PM | FDA Experience and Regulatory Considerations on Companion Diagnostics and Cancer Early Detection Test Sharon Liang, MD, PhD , RVC, VP, Regulatory Affairs and Quality Affairs, Burning Rock Dx. |
| 3:45 PM – 4:00 PM | A World-Class Healthcare Technology Innovation Platform at Hong Kong Science Park Carrie Ling, PhD, Assistant Director of Business Development (InnoHK) HKSTP |
| 4:00 PM – 4:05 PM – Conference Adjourned | |
| 4:05 PM – 4:30 PM – Breakroom Networking | |